Covalon is a widely held public company listed on the TSX Venture Exchange (Ticker: COV) since 2004. Covalon's patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Our technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. Our corporate offices and laboratories are located in Mississauga, Canada.
Our team of scientists hold advanced degrees in chemistry, biology, physics, and engineering and are recognized in the medical industry as leading experts in:
- Customized medical device coatings
- Antimicrobial and infection control technologies
- Advanced wound care dressings
- Advanced drug delivery technologies
Covalon’s broad footprint of proprietary and patented technologies, licensed by many leading medical companies, provide demonstrated benefits of product differentiation, improved efficacy, new revenue potential, and faster time to market for their offerings.
At Covalon, we know how to commercialize medical technology. We have a strong quality control system as an ISO 13485:2003 company and have participated in dozens and dozens of regulatory filings in the United States, Canada, Europe and other international jurisdictions including holding over a dozen regulatory licenses ourselves.
Covalon has built a network of highly respected contract manufacturers, independent testing laboratories and distribution partners to rapidly bring new healthcare products into the market.